What Has Led Bristol-Myers Squibb's Stock To Fall More Than 35% Over The Last 3 Years?Forbes • 08/15/19
BMY Stock Plus Celgene Will Be A Top 5 Pharma — But Should You Buy It?Investors Business Daily • 08/08/19
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024The Motley Fool • 08/04/19
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/25/19
Pharma Giants Top Second-Quarter Estimates, But Only One Stock PopsInvestors Business Daily • 07/25/19
Bristol-Myers Squibb (BMY) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 07/25/19
Bristol-Myers tops revenue and profit expectations, but lowers full-year earnings guidanceMarket Watch • 07/25/19